Racial differences in risk factor management in the warfarin vs aspirin for symptomatic intracranial disease trial

被引：0
|
作者：
Waddy, S
Cotsonis, G
Lynn, M
Frankel, M
Chaturvedi, S
Chimowitz, M
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Wayne State Univ, Detroit, MI USA
来源：
STROKE | 2006年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [31] Heart Matters: Gender and Racial Differences Cardiovascular Disease Risk Factor Control Among Veterans
    Goldstein, Karen M.
    Melnyk, S. Dee
    Zullig, Leah L.
    Stechuchak, Karen M.
    Oddone, Eugene
    Bastian, Lori A.
    Rakley, Susan
    Olsen, Maren K.
    Bosworth, Hayden B.
    WOMENS HEALTH ISSUES, 2014, 24 (05) : 477 - 483
  • [32] Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
    Shen, Albert Yuh-Jer
    Yao, Janis F.
    Brar, Somjot S.
    Jorgensen, Michael B.
    Chen, Wansu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (04) : 309 - 315
  • [33] Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Alings, Marco
    Atar, Dan
    Aylward, Philip
    Goto, Shinya
    Hanna, Michael
    Huber, Kurt
    Husted, Steen
    Lewis, Basil S.
    McMurray, John J. V.
    Pais, Prem
    Pouleur, Hubert
    Steg, Philippe Gabriel
    Verheugt, Freek W. A.
    Wojdyla, Daniel M.
    Granger, Christopher B.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2014, 35 (04) : 224 - 232
  • [34] Racial Differences in Albuminuria and Risk of Coronary Heart Disease
    Gutierrez, Orlando
    Khodneva, Yulia
    Muntner, Paul
    Rizk, Dana
    McClellan, William
    Cushman, Mary
    Warnock, David
    Safford, Monika
    CIRCULATION, 2013, 127 (12)
  • [35] Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy
    Limdi, N. A.
    Beasley, T. M.
    Allison, D. B.
    Rivers, C. A.
    Acton, R. T.
    BLOOD CELLS MOLECULES AND DISEASES, 2006, 37 (02) : 100 - 106
  • [36] Racial/ethnic differences in low-dose aspirin use for preeclampsia risk reduction
    Teal, E. Nicole
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S294 - S295
  • [37] Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management
    Vellimana, Ananth K.
    Ford, Andria L.
    Lee, Jin-Moo
    Derdeyn, Colin P.
    Zipfel, Gregory J.
    NEUROSURGICAL FOCUS, 2011, 30 (06)
  • [38] Racial differences and the risk of cardiovascular disease in chronic kidney disease.
    Weiner, DE
    Tighiouart, H
    Amin, MG
    Stark, PC
    MacLeod, B
    Salem, DN
    Levey, AS
    Sarnak, MJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 288A - 288A
  • [39] In THA or TKA, risk for symptomatic VTE was higher with aspirin vs. enoxaparin at 90 d
    Garcia, David
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (12) : JC141 - JC141
  • [40] Treatment of symptomatic intracranial atherosclerotic disease in the posterior circulation: Medical treatment vs stent
    Povedano, Guillermo P.
    Zuberbuller, Paz
    Ameriso, Sebastian
    NEUROLOGY, 2008, 70 (11) : A22 - A23
12345